Continuing its push to grow through acquisitions, global diagnostic testing leader Quest Diagnostics (Madison, New Jersey) said Friday that it would add Celera (Alameda, California), a pioneering genetic diagnostics firm, in a merger deal valued at just over $670 million. (Medical Device Daily) Read More
